Products 585543-15-3
CAS 585543-15-3 appears in our catalog under these names: Losmapimod, Losmapimod/ 99.05% (existing batch purity), Losmapimod 99% (HPLC), Losmapimod, 99% (HPLC), 99% (HPLC), Losmapimod, 99.94%. Offered by: TRC, TargetMol, GLPBio, Ambeed, Chemat. Available pack sizes: 750mg, 2mg, 5mg, 10mg, 25mg, 50mg, 100mg, 500mg.
Losmapimod is a secondary carboxamide resulting from the formal condensation of the carboxy group of 6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]pyridine-3-carboxylic acid with the amino group of neopentylamine. It is a potent p38alpha/beta mitogen activated protein kinase inhibitor which was previously in clinical trials for the treatment of facioscapulohumeral muscular dystrophy trial now discontinued due to not achieving its primary endpoint. It has a role as a nootropic agent, an anti-inflammatory agent, a cardioprotective agent and an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a secondary carboxamide, a member of benzamides, a pyridinecarboxamide, a member of toluenes, a phenylpyridine, a member of cyclopropanes and a member of monofluorobenzenes.
Source: ChEBI
| Molecular formula | C22H26FN3O2 |
|---|---|
| Molecular weight | 383.5 g/mol |
| IUPAC name | 6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide |
| InChIKey | KKYABQBFGDZVNQ-UHFFFAOYSA-N |
| SMILES | CC1=C(C=C(C=C1F)C(=O)NC2CC2)C3=NC=C(C=C3)C(=O)NCC(C)(C)C |
Computed by PubChem (NCBI)